The Oncologist: Immunogenicity of an Inactivated Monovalent 2009 Influenza A (H1N1) Vaccine in Patients Who Have Cancer (prospective single site study + 2 related articles))

Blogger's Note: reminder - full access requires subscription ($$$); note also related articles 

Abstract  
Background. The immune response of patients who have cancer, who may be receiving immunosuppressive therapy, is generally considered to be decreased. This study aimed to evaluate the immune response of cancer patients to the 2009 influenza A (H1N1) vaccine.

COMMENTARY

---

Vaccination of Oncology Patients: An Effective Tool and an Opportunity Not to Be Missed

Camille N. Kotton, Mark C. Poznansky

Oncologist published 12 January 2012, 10.1634/theoncologist.2011-0383
http://theoncologist.alphamedpress.org/cgi/reprint/theoncologist.2011-0383v1
.......................................................................................

OUTCOMES RESEARCH: CASE REPORT

---

Immunogenicity of an Inactivated Monovalent 2009 Influenza A (H1N1) Vaccine in Patients Who Have Cancer

Yiqing Xu, Nanda Methuku, Praveena Coimbatore, Theresa Fitzgerald, Yiwu Huang, Ying-Yi Xiao, Murali Pagala, Shachi Gupta, William Solomon, Philip Rubin, John Treanor, Alan Astrow, Howard Minkoff, Jay S. Cooper

Oncologist published 12 January 2012, 10.1634/theoncologist.2011-0220
http://theoncologist.alphamedpress.org/cgi/content/abstract/theoncologist.2011-0220v1